AA
PTLA

AQR Arbitrage’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

AQR Arbitrage’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,492,287
Closed -$26.8M – 678
2020
Q2 		$26.8M Buy
+1,492,287
New +$20.8M 1.19% 20

AQR Arbitrage's PTLA Position: Q3 2020 in Review

AQR Arbitrage sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 1,492,287 shares — an estimated $26.8M sold.

AQR Arbitrage first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $26.8M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • AQR Arbitrage reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • AQR Arbitrage sold 1,492,287 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $26.8M.
  • AQR Arbitrage first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • AQR Arbitrage's Portola Pharmaceuticals, Inc. position peaked at $26.8M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on AQR Arbitrage's 13F filing for Q3 2020, filed 16 Nov 2020.